The Alzheimer's Drug Discovery Foundation, based in New York City, will provide Melbourne, Australia-based Prana Biotechnology an investment of $700,000 over two years to conduct a clinical trial investigating the potential of PBT2 to reduce the accumulation of beta-amyloid in the brain of people with Alzheimer's disease. PET amyloid neuroimaging and other biomarkers will be used as the primary outcome measures.

NEW ORLEANSACC tackled tough questions associated with the use of integrated cardiovascular imaging and suggested that demonstrating improved patient outcomes and cost-effectiveness is quite complex but absolutely necessary. The specialty of cardiology needs to embrace randomized controlled trials to delineate the value of and roles for cardiac imaging modalities, according to a panel of experts in an Integrated Imaging Spotlight session held Sunday at the annual meeting of the American College of Cardiology.

A variety of factors play into the cost of an office visit, according to the latest Healthcare Transparency Index from change:healthcare.

Advanced Cell Diagnostics (ACD), and Definiens have partnered to develop image analysis applications that will enable researchers to quantify RNA molecules in routine clinical specimens.

Aposense has signed a material transfer agreement with the University of Pittsburgh, in which the university will have the right to use Aposense technology in a clinical trial in patients with glioblastoma multiforme type brain cancer funded by the National Institutes of Health (NIH).

Despite Medicares divisive denial of coverage for any CT colonography (CTC) cancer screening in 2009, Medicare claims show a spike in the procedures wider use and a dramatic increase in reimbursement rates for diagnostic CTC, according to a study published April 4 in the Journal of the American College of Radiology.

Overall cancer incidence in the U.S. decreased by nearly 1 percent per year between 2003 and 2007, with mortality falling by twice that figure across all four years, thanks largely to advances in diagnostic imaging, showed the findings of a report published in the April edition of the Journal of the National Cancer Institute.

In the current era of media-driven social amplification of radiation risk, authors of a clinical perspective published in the April edition of the American Journal of Roentgenology provided strategies for managing radiophobia and communicating the risks and benefits of diagnostic imaging to patients.